论文部分内容阅读
目的对沐舒坦在小儿支气管炎肺炎中的应用进行分析。方法取本院2015年1月份到2016年12月份收治的80例小儿支气管肺炎患儿为研究对象。分成两组,40例患儿实施常规治疗,设为对照组;40例患儿实施沐舒坦治疗,设为实验组。观察患儿的治疗效果,并进行比较。结果治疗效果以实验组最佳,总有效率高于对照组,比较有显著差异,P<0.05,存在统计学意义;患儿症状恢复时间以实验组最短,与对照组比较有显著差异性,P<0.05,存在统计学意义。40例实验组患儿中,有3例患儿存在轻度胃肠道反应,无特殊处理,症状自行消除,无其余不良反应发生。结论小儿支气管肺炎采用沐舒坦进行治疗,能够消除患儿疾病症状,改善患儿肺功能,促进患儿康复。
Objective To analyze the application of Mucosolvan in pediatric bronchitis pneumonia. Methods Totally 80 children with bronchial pneumonia admitted from January 2015 to December 2016 in our hospital were enrolled in this study. Divided into two groups, 40 cases of children underwent routine treatment, as the control group; 40 cases of patients with mucosolvan treatment, as the experimental group. Observe the treatment effect of children, and compare. Results The treatment effect was best in the experimental group and the total effective rate was higher than that in the control group, P <0.05, there was statistical significance; the symptom recovery time was the shortest in the experimental group, significant difference compared with the control group, P <0.05, there is statistical significance. Among the 40 experimental groups, 3 patients had mild gastrointestinal reactions without any special treatment, and the symptoms were eliminated by themselves without any adverse reaction. Conclusion Pediatric bronchial pneumonia treated with mucosolvan can eliminate the symptoms of children with diseases, improve the lung function and promote the recovery of children.